LEVERAGING BEHAVIOURAL SCIENCE TO IMPROVE PATIENT ADHERENCE AND OVERALL OUTCOMES


IQVIA, Novartis, AbbVie and Merck Group present a Webinar for all.

Patient behaviour plays a crucial role in adherence and the success of treatments. Healthcare professionals (HCPs) who understand patient behaviour and behavioural models and frameworks can design more successful patient support programs.

Knowing the physical and psychological strains of a patient’s illness and his/her behavioural response also allows HCPs to empathize and better communicate with them listen to experts from IQVIA, Abbvie, Merck and Novartis on how to better-design treatment structures for improved outcomes.

Date: October 23, 2019

Time: 14:30 to 16:00 (UAE Time)

Register

The webinar talks about the Bio-Psycho-Social (BPS) model, Capability-Opportunity-Motivation Behaviour (COM-B) framework, and how companies can benefit from understanding patient behaviour.

Experts will elaborate on how pharmaceuticals can better design and structure treatments in ways that improve patient and caregiver experiences, and how Pharmaceutical companies can help patients improve their medication adherence and self-management, leading to better health outcomes, quality of life and reduced burden on the healthcare system.

Speakers:

Dr. Clare Moloney: Programme Insights and Design Lead, Medical and Patient Communications, IQVIA

Laila Elsergani, Patient Advocacy Manager and Patient Oriented Program Champion, Novartis

Rania Rafik, Medical Manager, Merck Group, Egypt

Roula Anka Patient Experience Manager, Levant, Iran & Pakistan, AbbVie

Rula Nosseir Engagement Manager, Patient Services, IQVIA

Register Now:

© 2020 by SACRA. Proudly created with Wix.com

GET MORE FROM SACRA

  • White LinkedIn Icon
  • Facebook Clean
  • Twitter Clean